0001127602-24-008124.txt : 20240304 0001127602-24-008124.hdr.sgml : 20240304 20240304161913 ACCESSION NUMBER: 0001127602-24-008124 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPIO THOMAS CENTRAL INDEX KEY: 0001683323 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 24715199 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-29 0000885590 Bausch Health Companies Inc. BHC 0001683323 APPIO THOMAS 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 1 Chief Executive Officer 0 Common Shares, No Par Value 2024-02-29 4 A 0 519328 0 A 1486338 D Common Shares, No Par Value 2024-03-01 4 F 0 2895 9.89 D 1483443 D Common Shares, No Par Value 2024-03-01 4 F 0 2413 9.89 D 1481030 D Common Shares, No Par Value 2024-03-01 4 F 0 23871 9.89 D 1457159 D Common Shares, No Par Value 2024-03-01 4 F 0 87803 9.89 D 1369356 D Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. /s/ Brianna M. Cetrulo, attorney-in-fact 2024-03-04